Susquehanna International Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.64M | Buy |
112,179
+103,312
| +1,165% | +$2.64M | ﹤0.01% | 5541 |
|
|
2025
Q4 | $257K | Sell |
8,867
-56,729
| -86% | -$1.45M | ﹤0.01% | 10306 |
|
|
2025
Q3 | $1.24M | Sell |
65,596
-195,391
| -75% | -$3.08M | ﹤0.01% | 6833 |
|
|
2025
Q2 | $3.66M | Buy |
260,987
+92,363
| +55% | +$1.29M | 0.01% | 4567 |
|
|
2025
Q1 | $2.64M | Buy |
168,624
+104,523
| +163% | +$1.47M | ﹤0.01% | 4921 |
|
|
2024
Q4 | $893K | Buy |
64,101
+13,814
| +27% | +$151K | ﹤0.01% | 7250 |
|
|
2024
Q3 | $468K | Sell |
50,287
-4,396
| -8% | -$43.4K | ﹤0.01% | 8615 |
|
|
2024
Q2 | $509K | Sell |
54,683
-45,538
| -45% | -$412K | ﹤0.01% | 8225 |
|
|
2024
Q1 | $993K | Sell |
100,221
-228,656
| -70% | -$1.71M | ﹤0.01% | 6937 |
|
|
2023
Q4 | $1.06M | Buy |
328,877
+290,584
| +759% | +$790K | ﹤0.01% | 6851 |
|
|
2023
Q3 | $203K | Buy |
38,293
+23,412
| +157% | +$199K | ﹤0.01% | 10197 |
|
|
2023
Q2 | $142K | Sell |
14,881
-91,473
| -86% | -$1.02M | ﹤0.01% | 10629 |
|
|
2023
Q1 | $1.17M | Buy |
106,354
+84,052
| +377% | +$1.22M | ﹤0.01% | 6402 |
|
|
2022
Q4 | $330K | Sell |
22,302
-38,193
| -63% | -$667K | ﹤0.01% | 8863 |
|
|
2022
Q3 | $1.16M | Buy |
60,495
+25,814
| +74% | +$585K | ﹤0.01% | 6264 |
|
|
2022
Q2 | $739K | Buy |
34,681
+15,249
| +78% | +$313K | ﹤0.01% | 7271 |
|
|
2022
Q1 | $374K | Sell |
19,432
-2,935
| -13% | -$49.7K | ﹤0.01% | 9715 |
|
|
2021
Q4 | $464K | Sell |
22,367
-1,168
| -5% | -$23.2K | ﹤0.01% | 9402 |
|
|
2021
Q3 | $562K | Buy |
23,535
+4,945
| +27% | +$113K | ﹤0.01% | 9065 |
|
|
2021
Q2 | $507K | Sell |
18,590
-16,412
| -47% | -$462K | ﹤0.01% | 9561 |
|
|
2021
Q1 | $1.01M | Buy |
35,002
+23,828
| +213% | +$744K | ﹤0.01% | 7710 |
|
|
2020
Q4 | $314K | Sell |
11,174
-22,623
| -67% | -$554K | ﹤0.01% | 9164 |
|
|
2020
Q3 | $990K | Buy |
33,797
+22,205
| +192% | +$593K | ﹤0.01% | 6143 |
|
|
2020
Q2 | $351K | Buy |
+11,592
| New | +$335K | ﹤0.01% | 8070 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
